Corey Davis | LifeSci Advisors |
Glenn Mattes | President, CEO & Director |
Kirk Coleman | Chief Financial Officer |
Dale Christensen | Director of Clinical Development |
Chris Cano | Chief Operating Officer. |
Bill Williams | University of Texas at Austin |
Jonathan Aschoff | ROTH Capital Partners |
Daniel Carlson | TW Research Group |
Michael Okunewitch | Maxim Group |
Thank you for standing by. This is the conference operator. Welcome to the TFF Pharmaceuticals Second Quarter 2022 Earnings Conference Call.
As a reminder, all participants are in listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions.